COULD PERSONALIZED MEDICINE BECOME A CRITICAL WEAPON IN THE FIGHT AGAINST OPIOID ADDICTION?

 

RESEARCHERS SAY THAT A NEW GENETIC TEST CAN HELP CLINICIANS IDENTIFY WHO MIGHT BE PRE-DISPOSED TO BECOME HOOKED ON OPIOIDS.

STUDY FINDINGS ARE BEING PRESENTED DURING THE LARGEST U.S. PAIN CONFERENCE FOR DOCTORS WITH AN INTEREST IN PAIN MANAGEMENT, WHICH IS GETTING UNDERWAY IN LAS VEGAS.

HERE NOW IS CONFERENCE PARTICIPANT DR KERI J. DONALDSON FROM PREDICTIVE HEALTH INTELLIGENCE COMPANY PRESCIENT MEDICINE, TO EXPLAIN THE LATEST EFFORTS IN THE WAR ON OPIOID ABUSE.

·         TELL US WHY YOU WERE LOOKING AT THE ROLE OF GENETICS IN OPIOID ADDICTION AND ABUSE?

·         HOW WAS THE STUDY DESIGNED AND WHAT DID THE RESULTS SHOW?

·         HOW CONFIDENT CAN CLINICIANS BE IN THE RESULTS OF THIS TEST?

·         HOW IMPORTANT ARE TOOLS LIKE THIS IN HELPING THE MEDICAL COMMUNITY PREVENT THE POTENTIAL FOR OPIOID DEPENDENCY AND ABUSE?

·         WHERE CAN WE GET MORE DETAILS ON THE RESEARCH AND ON THIS NEW TEST?

 

Dr. Keri Donaldson is the Director of the Clinical Processing Specimen Laboratory and the Director of the CLIA Laboratory.